Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 65
- By:
- Publication type:
- Article
Works matching IS 11791438 AND DT 2010 AND VI 2
Results: 28
1
2
Nanoparticle-labeled stem cells: a novel therapeutic vehicle.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 9
- By:
- Publication type:
- Article
3
Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 83
- By:
- Publication type:
- Article
4
Pharmacologic agents for smoking cessation: A clinical review.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 17
- By:
- Publication type:
- Article
5
Adverse drug effects in hospitalized elderly: Data from the Healthcare Cost and Utilization Project.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 41
- By:
- Publication type:
- Article
6
The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus disease.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 1
- By:
- Publication type:
- Article
7
Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 77
- By:
- Publication type:
- Article
8
NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 31
- By:
- Publication type:
- Article
9
Induction chemotherapy before autologous stem cell transplantation for symptomatic plasma cell myeloma -- does it matter?
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 71
- By:
- Publication type:
- Article
10
Editorial Foreword.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 223, doi. 10.2147/CPAA.S16022
- By:
- Publication type:
- Article
11
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 225, doi. 10.2147/CPAA.S15369
- By:
- Publication type:
- Article
12
Intrapleural therapy in management of complicated parapneumonic effusions and empyema.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 213, doi. 10.2147/CPAA.S14104
- By:
- Publication type:
- Article
13
Clinical efficacy of beta 1 selective adrenergic blockers in the treatment of neurocardiogenic syncope -- a meta-analysis.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 163, doi. 10.2147/CPAA.S12873
- By:
- Publication type:
- Article
14
Reporting of results of interventional studies by the information service of the National Institutes of Health.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 169, doi. 10.2147/CPAA.S12398
- By:
- Publication type:
- Article
15
Analgesic efficacy of oral gabapentin added to standard epidural corticosteroids in patients with failed back surgery.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 207, doi. 10.2147/CPAA.S12126
- By:
- Publication type:
- Article
16
Mitochondrial therapy for Parkinson's disease: Neuroprotective pharmaconutrition may be disease-modifying.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 185, doi. 10.2147/CPAA.S12082
- By:
- Publication type:
- Article
17
Testosterone replacement in male hypogonadism.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 149, doi. 10.2147/CPAA.S11940
- By:
- Publication type:
- Article
18
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 177, doi. 10.2147/CPAA.S11795
- By:
- Publication type:
- Article
19
A comparative study of DNA damage in patients suffering from diabetes and thyroid dysfunction and complications.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 199, doi. 10.2147/CPAA.S11366
- By:
- Publication type:
- Article
20
Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 123
- By:
- Publication type:
- Article
21
Differences in hospital glycemic control and insulin requirements in patients recovering from critical illness and those without prior critical illness.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 143, doi. 10.2147/CPAA.S11259
- By:
- Publication type:
- Article
22
Managing insulin resistance: role of liraglutide.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 131
- By:
- Publication type:
- Article
23
Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 89
- By:
- Publication type:
- Article
24
The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 155, doi. 10.2147/CPAA.S9807
- By:
- Publication type:
- Article
25
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 95
- By:
- Publication type:
- Article
26
Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 111
- By:
- Publication type:
- Article
27
Rituximab in severe skin diseases: target, disease, and dose.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 135
- By:
- Publication type:
- Article
28
A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity.
- Published in:
- Clinical Pharmacology, 2010, v. 2, p. 105
- By:
- Publication type:
- Article